Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Analyst Moves: AEGR, DPZ

Forbes - 27 Dec 2012 18:44
Aegerion Pharmaceuticals (AEGR) had its price target increased by Jefferies (JEF) to $29 with a buy rating, as the approval of Juxtapid should add to earnings.
Full Article at Forbes

More Market News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard